Precision BioSciences, Inc. (DTIL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 53.36M |
| Enterprise Value | -28.66M |
| P/E Ratio | -7.45 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 5.68 |
| Price/Book Ratio | 4.85 |
| Enterprise/Revenue | 4.48 |
| Enterprise/EBITDA | -4.14 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.86 |
| Operating Margin | -0.8 |
| Return On Assets | -0.32 |
| Return On Equity | -0.58 |
| Revenue | 34.26M |
| Revenue/Share | 1.64 |
| Gross Profit | 34.26M |
| EBITDA | -42.43M |
| Net Income | -45.72M |
| Diluted EPS | -3.56 |
| Total Cash | 81.85M |
| Total Cash/Share | 2.98 |
| Total Debt | 27.72M |
| Total Debt/Equity | 0.54 |
| Current Ratio | 10.47 |
| Book Value Per Share | 1.89 |
| 52-Week Change | 52.67 |
| 52-Week High | 11.29 |
| 52-Week Low | 3.53 |
| Moving Average 50 Days | 6.97 |
| Moving Average 200 Days | 6.7 |
| Average Volume | 314,934 |
| Shares Outstanding | 27.94M |
| % Held by Institutions | 68.82 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | February 14, 2024 |